Navigate to the red box on the right to view and download SAMU supported publications from 2019.

Articles include:
From Q1:

• Beyond 'cure' and 'treatment success': quality of life of patients with multidrug-resistant tuberculosis
• Delays in seeking care and treatment for advanced HIV disease in Kinshasa, DRC
• Mortality in the first six months among HIV-positive and HIV-negative patients empirically treated for tuberculosis
• The Continuing Value of CD4 Cell Count Monitoring for Differential HIV Care and Surveillance
• Demanding an end to tuberculosis: treatment of tuberculosis infection among persons living with and without HIV

From Q2:

• Bedaquiline and delamanid in combination for treatment of drug-resistant tuberculosis
• Patient and health-care worker experiences of an HIV viral load intervention using SMS: A qualitative study
• Bedaquiline Microheteroresistance after Cessation of Tuberculosis Treatment
• The STREAM trial: missed opportunities and lessons for future clinical trials
• Investigating the addition of oral HIV self-tests among populations with high testing coverage
• Outcomes of patients in clubs after recent viral suppression
• Simplifying switch to second-line antiretroviral therapy
• Breast Tuberculosis in Women: A systematic Review
• The missed potential of CD4 and viral load testing
• ART adherence clubs in Khayelitsha and Gugulethu
• HIV virological failure in Mozambique
• Performance of Cepheid GeneXpert HIV-1 viral load plasma assay to accurately detect treatment failure
• Universal regimens or universal access to drug susceptibility testing for tuberculosis?

From Q3:

• A cluster randomized controlled trial of extending ART refill intervals to six-monthly for anti-retroviral adherence clubs
• Challenges and controversies in childhood tuberculosis
• The epidemiology of rape and sexual violence in the platinum mining district of Rustenburg, South Africa: Prevalence, and factors associated with sexual violence

• GeneXpert and Community Health Workers Supported Patient Tracing for TB Diagnosis in India
• Feasibility of using Determine TB-LAM to diagnose tuberculosis in HIV-positive patients in programmatic conditions
• Standardised shorter regimens versus individualised longer regimens for multidrug-resistant tuberculosis
• HIV viral load algorithm: what are the needs in the field?
• Diagnostic sensitivity of SILVAMP TB-LAM (FujiLAM) point-of-care urine assay for extrapulmonary TB in people living with HIV
• Distribution of advanced HIV disease from three high HIV prevalence settings in Sub-Saharan Africa
• Barriers and solutions to finding rifampicin-resistant tuberculosis cases in older children and adolescents
• Adverse events among people on delamanid for rifampicin-resistant tuberculosis in a high HIV prevalence setting
• Peer Mentorship via Mobile Phones for Newly Diagnosed HIV-Positive Youths in Clinic Care in Khayelitsha, South Africa
• Southern African HIV Clinicians Society guideline for the prevention, diagnosis and management of cryptococcal disease among HIV-infected persons
• New opportunities in tuberculosis prevention: implications for people living with HIV
• Scaling up HIV viral load monitoring in Manicaland, Zimbabwe: challenges and opportunities from the field